The main purpose of this study is to evaluate the efficacy and safety of M281 in participants with warm autoimmune hemolytic anemia (wAIHA).
- Investigator
- Anita Rajasekhar
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
Research at a glance
Top areas of exploration
- Venous Thromboembolism , 15 publications
- Anticoagulants , 9 publications
- Pulmonary Embolism , 8 publications
- Hematology , 6 publications
Research activity
Active clinical trials
- Investigator
- Anita Rajasekhar
- Status
- Accepting Candidates
My publications
Filter publications
50 publications
2023
Burnout in US hematologists and oncologists: impact of compensation models and advanced practice provider support.
Blood advances
PubMed • Publisher's site2023
Comment on: 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults.
Journal of the American Geriatrics Society
PubMed • Publisher's site2023
Long-term follow-up of patients with congenital thrombotic thrombocytopenia purpura receiving a plasma-derived factor VIII (Koate) that contains ADAMTS13.
Haemophilia : the official journal of the World Federation of Hemophilia
PubMed • Publisher's site2023
Real-world safety and effectiveness of recombinant porcine sequence factor VIII in acquired haemophilia A: A non-interventional, post-authorization safety study.
Haemophilia : the official journal of the World Federation of Hemophilia
PubMed • Publisher's site2023
Reducing unnecessary premedication prior to parenteral iron therapy: A quality improvement project.
Transfusion
PubMed • Publisher's site